These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17338425)
1. PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy. Bicanski B; Wenderdel M; Mertens PR; Senderek J; Panzer U; Steinmetz O; Stahl RA; Cerullo G; Diletta Torres D; Schena FP; Zerres K; Floege J Clin Nephrol; 2007 Feb; 67(2):65-72. PubMed ID: 17338425 [TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745 [TBL] [Abstract][Full Text] [Related]
3. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy. Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716 [TBL] [Abstract][Full Text] [Related]
4. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis. Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378 [TBL] [Abstract][Full Text] [Related]
5. Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy. Suzuki H; Sakuma Y; Kanesaki Y; Eiro M; Asahi K; Sanada H; Watanabe K; Katoh T; Watanabe T Clin Nephrol; 2004 Sep; 62(3):173-9. PubMed ID: 15481848 [TBL] [Abstract][Full Text] [Related]
7. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy. Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068 [TBL] [Abstract][Full Text] [Related]
8. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561 [TBL] [Abstract][Full Text] [Related]
9. Predictors of Progression in IgA Nephropathy in Childhood. Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979 [TBL] [Abstract][Full Text] [Related]
11. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone. Hwang YC; Lee TW; Kim MJ; Yang MH; Ihm CG Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896 [TBL] [Abstract][Full Text] [Related]
12. ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients. Han SY; Kwon YJ; Jo SK; Shin JH; Cha DR; Cho WY; Pyo HJ; Kim HK Korean J Intern Med; 2000 Jan; 15(1):13-8. PubMed ID: 10714086 [TBL] [Abstract][Full Text] [Related]
13. ACE gene sequence and nucleotide variants in IgA nephropathy. Woo KT; Lau YK; Chan CM; Zhao Y; Tan HB; Liu FE; Fook-Chong S; Wong KS Singapore Med J; 2011 Nov; 52(11):824-34. PubMed ID: 22173253 [TBL] [Abstract][Full Text] [Related]
14. Association of Zhong Z; Feng S; Shi D; Xu R; Yin P; Wang M; Mao H; Huang F; Li Z; Yu X; Li M DNA Cell Biol; 2019 Oct; 38(10):1155-1165. PubMed ID: 31433201 [TBL] [Abstract][Full Text] [Related]
15. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors]. Shi X; Chen X; Liu S; Zhuang Y; Zhang Y Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603 [TBL] [Abstract][Full Text] [Related]